264 related articles for article (PubMed ID: 27207165)
21. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
22. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
[TBL] [Abstract][Full Text] [Related]
23. Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway.
Ezaldein HH; Hill ST; Merati M; Suggs A; Reichert B; Scott JF
Lasers Surg Med; 2020 Nov; 52(9):837-841. PubMed ID: 32221981
[TBL] [Abstract][Full Text] [Related]
24. The current situation and development of medical device testing institutes in China.
Yang X; Mu R; Fan Y; Wang C; Li D
Expert Rev Med Devices; 2017 Apr; 14(4):263-269. PubMed ID: 28388243
[TBL] [Abstract][Full Text] [Related]
25. Mapping the genealogy of medical device predicates in the United States.
Pai DB
PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
[TBL] [Abstract][Full Text] [Related]
26. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
[TBL] [Abstract][Full Text] [Related]
27. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.
Rathi VK; Gadkaree SK; Ross JS; Kozin ED; Sethi RK; Naunheim MR; Puram SV; Gray ST
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):608-617. PubMed ID: 28786317
[TBL] [Abstract][Full Text] [Related]
28. Technology assessment of medical devices at the Center for Devices and Radiological Health.
Kessler L; Richter K
Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
[TBL] [Abstract][Full Text] [Related]
29. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications.
Tau N; Shepshelovich D
JAMA Intern Med; 2020 Nov; 180(11):1420-1426. PubMed ID: 32986074
[TBL] [Abstract][Full Text] [Related]
31. Food and Drug Administration control of medical devices: an inescapable intrusion and stimulus for adaptation.
Friedman EA
ASAIO J; 1998; 44(4):239-40. PubMed ID: 9682946
[No Abstract] [Full Text] [Related]
32. Improving medical device regulation: the United States and Europe in perspective.
Sorenson C; Drummond M
Milbank Q; 2014 Mar; 92(1):114-50. PubMed ID: 24597558
[TBL] [Abstract][Full Text] [Related]
33. The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care.
Jazowski SA; Winn AN
Curr Diab Rep; 2017 Jun; 17(6):40. PubMed ID: 28439847
[TBL] [Abstract][Full Text] [Related]
34. Off-Label Use of Medical Devices in Children.
;
Pediatrics; 2017 Jan; 139(1):. PubMed ID: 28025239
[TBL] [Abstract][Full Text] [Related]
35. The regulation of medical devices.
Wilmshurst P
BMJ; 2011 May; 342():d2822. PubMed ID: 21572131
[No Abstract] [Full Text] [Related]
36. Time to publication of cost-effectiveness analyses for medical devices.
Everhart AO
Am J Manag Care; 2023 May; 29(5):265-268. PubMed ID: 37229785
[TBL] [Abstract][Full Text] [Related]
37. The Interconnected Ancestral Network of Hip Arthroplasty Device Approval.
Premkumar A; Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A
J Am Acad Orthop Surg; 2021 Dec; 29(24):e1362-e1369. PubMed ID: 34161960
[TBL] [Abstract][Full Text] [Related]
38. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
[TBL] [Abstract][Full Text] [Related]
39. Shoulder arthroplasty device clearance: an ancestral network analysis.
Zhu A; Ying X; Carey EG; Pean CA; Premkumar A; Fu MC; Taylor SA
J Shoulder Elbow Surg; 2023 Mar; 32(3):671-676. PubMed ID: 36279987
[TBL] [Abstract][Full Text] [Related]
40. Median approval times for class III medical devices have been well above statutory deadlines set for FDA and CMS.
Zinn AM; Allen JC; Hacker CS
Health Aff (Millwood); 2012 Oct; 31(10):2304-13. PubMed ID: 23048112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]